Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
about
Clinical implications of determination of safe surgical margins by using a combination of CT and 18FDG-positron emission tomography in soft tissue sarcoma.Comparison of primary target volumes delineated on four-dimensional CT and 18 F-FDG PET/CT of non-small-cell lung cancerIntensity modulated radiotherapy (IMRT) with concurrent chemotherapy as definitive treatment of locally advanced esophageal cancer.Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.Targeted molecular imaging in oncology: focus on radiation therapy.Principles of modern radiation techniques for esophageal and gastroesophageal junction cancers.The clinical application of PET/CT: a contemporary review.Radical chemoradiotherapy for adenocarcinoma of the distal oesophagus and oesophagogastric junction: what planning margins should we use?PET/CT planning during chemoradiotherapy for esophageal cancer.PET and PET-CT in radiation treatment planning for lung cancer.Technological advances in radiotherapy for esophageal cancerUse of FDG-PET in Radiation Treatment Planning for Thoracic Cancers.The application of functional imaging techniques to personalise chemoradiotherapy in upper gastrointestinal malignancies.The development and testing of a digital PET phantom for the evaluation of tumor volume segmentation techniques.The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer.Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esCan hybrid FDG-PET/CT detect subclinical lymph node metastasis of esophageal cancer appropriately and contribute to radiation treatment planning? A comparison of image-based and pathological findings.Improving superficial target delineation in radiation therapy with endoscopic tracking and registration.Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer.The impact of hybrid PET-CT scan on overall oncologic management, with a focus on radiotherapy planning: a prospective, blinded study.Comparison of biological target volume metrics based on FDG PET-CT and 4DCT for primary non-small-cell lung cancer.18-Fluorodeoxy-Glucose Positron Emission Tomography- Computed Tomography (18-FDG-PET/CT) for Gross Tumor Volume (GTV) Delineation in Gastric Cancer Radiotherapy18 F-FDG PET/CT for planning external beam radiotherapy alters therapy in 11% of 581 patients.Does pre-operative estimation of oesophageal tumour metabolic length using 18F-fluorodeoxyglucose PET/CT images compare with surgical pathology length?PET lesion segmentation using automated iso-intensity contouring in head and neck cancer.New strategy for automatic tumor segmentation by adaptive thresholding on PET/CT images.
P2860
Q33966580-E6FC0907-AC7D-4BCA-AFF2-CEFB6D9D3236Q34116484-50034B42-6992-4C12-AC59-50F1F3252EE4Q34143984-FDE1BD81-9B29-4B09-A4FE-83A15B995C78Q36074242-25E9CFD2-6F1C-4D3B-B4D7-7B7CA2C5D11CQ36528175-D04C28CB-DDE3-4486-96BF-2C09EAA2D83DQ37198637-4BCD3370-4DD4-4873-98A9-539FB9433BECQ37242165-157C8DE0-38CC-4940-A8CC-DBCF60DE13B7Q37270111-5926008A-1F5B-4F76-A2C8-539814E71DD4Q37687303-837E7E63-1F66-450F-8251-6BE6646746A2Q37732292-41D01F4E-9D20-48AB-9F98-65E68BA903BDQ37812088-2D9D494B-6C80-404E-B0DF-9947807A50F4Q38016163-0BE6F981-1634-4C8B-89F9-9E72F9FE6BDBQ38226697-29F38BC0-232E-4CDE-8C3B-3EE7BF45452EQ38781329-7CE7B40D-8FF9-4C70-8508-E44E988A49A8Q42174594-481C7334-0DE6-434E-830E-23E96C4608D5Q43180457-A50ECEAC-51CB-47E4-9B9F-C16CEC719678Q43255213-05DD0E86-A0BE-468F-BDAC-F4AF7B55DEAAQ45423893-F1875C1B-605D-4561-BAD8-DC8248BA85F2Q46049376-DDEB855B-031B-479B-9AFC-40A5AC68ABF1Q46873535-6D3AD160-BB69-4C57-A03F-3977CE994DE3Q47118767-BAAD5211-7806-4740-BFFB-48241F3C78C7Q47418845-788645D9-1A98-427A-8C6C-B84B01BC743DQ48840884-8BED65B0-FC31-4179-A091-1C3C09807B66Q53255081-A013FB39-1EFD-4D20-B0F2-4EA88ED16913Q53341371-E471DA3F-953B-437E-BA50-FAFF5C698A71Q55033353-5BCD0B5D-2363-409D-8C74-F8A12C84AD56
P2860
Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Impact of hybrid fluorodeoxygl ...... nd non-small-cell lung cancer.
@en
type
label
Impact of hybrid fluorodeoxygl ...... nd non-small-cell lung cancer.
@en
prefLabel
Impact of hybrid fluorodeoxygl ...... nd non-small-cell lung cancer.
@en
P2093
P1476
Impact of hybrid fluorodeoxygl ...... and non-small-cell lung cancer
@en
P2093
Andy Howard
Deepak Khuntia
Kristin Bradley
Mark Ritter
Vinai Gondi
P304
P356
10.1016/J.IJROBP.2006.09.033
P407
P577
2007-01-01T00:00:00Z